Latest news
INSPIRE completes Part 2 - University of the Philippines DilimanUniversity of the Philippines Diliman · Tue, 11 Aug 2026 03:34:46 GMTClearmind's CMND-100 trial reaches 160 mg with no serious adverse events - Stock TitanStock Titan · Thu, 30 Jul 2026 12:30:00 GMT24 Participants Complete Treatment in Clearmind's Alcohol Use Disorder Trial - Stock TitanStock Titan · Tue, 28 Jul 2026 07:00:00 GMTClearmind Medicine Completes Treatment of All Participants in Part A of Phase I/II AUD Trial for CMND-100 - Quiver QuantitativeQuiver Quantitative · Tue, 28 Jul 2026 07:00:00 GMTClearmind Medicine Successfully Completes Part A of its FDA Regulated Phase I/II Trial - The Manila TimesThe Manila Times · Tue, 28 Jul 2026 07:00:00 GMTAscension Parish completes its part of LAlumina "red dust" plant cleanup - Unfiltered with KiranUnfiltered with Kiran · Tue, 28 Jul 2026 07:00:00 GMT